Paul Whiteley/ LinkedIn
Jun 24, 2026, 17:36
Paul Whiteley: Neurodevelopmental and Autism Risks in Fetal and Neonatal Alloimmune Thrombocytopenia
Paul Whiteley, Autism Researcher, shared a post on X about a recent article by Abdelaziz Hendy et al. published in Evidence-Based Nursing, adding:
” ‘All children with fetal neonatal alloimmune thrombocytopenia should have long-term structured neurodevelopmental and autism screening even if they do not have an intracranial haemorrhage (ICH)‘
Another one of the autisms.
And following an immune disorder.”
Title: Are higher autism rates in FNAIT without intracranial haemorrhage real or a result of increased screening?
Authors: Abdelaziz Hendy, Abdulqadir J Nashwan
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 29, 2026, 03:53Nahrwan Masaoodi: Iron Deficiency Can Exist Without Anemia
-
Sep 29, 2026, 03:38Muhammad Yousaf: Iron Deficiency Beyond Diet
-
Sep 29, 2026, 03:21Parvez Ahmed Chowdhury: Synthesizing Aspirin in the Organic Chemistry Lab
-
Sep 29, 2026, 03:12Ahmed Hamandi: Building the Future of Hematopoietic Transplantation in Iraq
-
Sep 29, 2026, 03:09M V Chandrakanth: Aspirin in CRC – Old Drug, New Precision Oncology?
-
Sep 29, 2026, 03:07Caroline Pothet: Advancing Treatment Development in Sickle Cell Disease and Thalassaemia
-
Sep 29, 2026, 02:53Astha Jain: Thalassemia Care Through a Public Health Lens
-
Sep 29, 2026, 02:50Emma Groarke: Starting a New Career Path in Homeland
-
Sep 28, 2026, 19:14Aditya Sharma: An Outstanding Start to the Final Day of VSS 2026!